COLLABORATIVE GROUP OF THE AMERICA… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2012

Legal Domicile

Principal Officer

BRYSON KATONA MD PHD CGAF

Phone

6143219676

Tax Period

2024-01-01 to 2024-12-31

COLLABORATIVE GROUP OF THE AMERICAS INHERITED GASTROINTESTINAL CANCER, founded in 2012, is a small nonprofit in the Diseases & Disorders sector that reported $311K in total revenue in fiscal year 2024. Revenue surged 68% from the prior year, signaling strong growth momentum. The organization ran a surplus of $179K, a strong 58% operating margin.

Mission

THE MISSION OF THE COLLABORATIVE GROUP OF THE AMERICAS ON INHERITED GASTROINTESTINAL CANCER IS TO OFFER: -EDUCATION REGARDING THE CLINICAL MANAGEMENT AND MOLECULAR GENETICS OF INHERITED GASTROINTESTINAL CANCER TO PHYSICIANS, ALLIED HEALTHCARE PROFESSIONALS, PATIENTS, AND THEIR FAMILIES. -ACCESS TO COLLABORATIVE TRIALS AND STUDIES. -RESOURCES FOR DEVELOPING NEW HEREDITARY REGISTRIES AND SUPPORTING THEIR REGISTRIES. -A FORUM FOR EXCHANGE OF IDEAS. -MULTIDISCIPLINARY EXPERTISE IN CLINICAL CARE, HEALTHCARE POLICY, AND RESEARCH RELATED TO HEREDITARY GASTROINTESTINAL CANCER.

Program Service Accomplishments

Program 1

Expenses: $132,254 Revenue: $194,440

COLLABORATIVE GROUP OF THE AMERICAS ON INHERITED GASTROINTESTINAL CANCER IS DEVOTED TO THE PURSUIT OF PROVIDING CUTTING EDGE EDUCATION REGARDING THE CLINICAL MANAGEMENT AND MOLECULAR GENETICS OF...

COLLABORATIVE GROUP OF THE AMERICAS ON INHERITED GASTROINTESTINAL CANCER IS DEVOTED TO THE PURSUIT OF PROVIDING CUTTING EDGE EDUCATION REGARDING THE CLINICAL MANAGEMENT AND MOLECULAR GENETICS OF INHERITED GASTROINTESTINAL CANCER TO PHYSICIANS AND ALLIED HEALTH CARE PROFESSIONALS. THIS IS ACHIEVED PRIMARILY THROUGH CONTINUING MEDICAL EDUCATION AND BY PROVIDING A FORUM FOR THE EXCHANGE OF IDEAS AT THE ANNUAL MEETING. COLLABORATIVE GROUP OF THE AMERICAS ON INHERITED GASTROINTESTINAL CANCER AIMS TO ENCOURAGE PROFESSIONAL GROWTH, SIMULATE INTELLECTUAL CURIOSITY, AND IMPROVE PATIENT OUTCOMES BY EXPANDING ACCESS TO UP-TO-DATE INFORMATION OF INTEREST TO PRACTITIONERS AND RESEARCHERS. THE ANNUAL MEETING IS DESIGNED TO KEEP CLINICIANS AND SCIENTISTS UP-TO-DATE ON NEW DEVELOPMENTS IN HEREDITARY GASTROINTESTINAL CANCER RESEARCH, INCLUDING IMPLICATIONS IN THE PREVENTION, DIAGNOSIS, AND TREATMENT OF PATIENTS WITH THE HEREDITARY GASTROINTESTINAL CANCER SYNDROMES. THE PROGRAM IS DIRECTED TO COLORECTAL SURGEONS, MEDICAL ONCOLOGISTS, GASTROENTEROLOGISTS, RESEARCHERS, GENETICISTS, NURSES, COLORECTAL CANCER REGISTRY COORDINATORS, GENETIC COUNSELORS, PSYCHOLOGISTS AND OTHER HEALTH CARE PROFESSIONALS INVOLVED IN THE CARE OF INDIVIDUALS WITH HEREDITARY GASTROINTESTINAL CANCERS, INCLUDING COLORECTAL, ESOPHAGEAL, PANCREATIC, GASTRIC AND SMALL BOWEL CANCERS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $98,527

Program Service Revenue $194,440

Investment Income $18,446

Other Revenue $0

TOTAL REVENUE $311,413

Expense Breakdown

Grants Paid $30,000

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $132,254

Other Expenses $102,254

TOTAL EXPENSES $132,254

Year-over-Year Comparison

	2024	2023	Change
Revenue	$311,413	$185,543	+0.7%
Expenses	$132,254	$127,595	+0.0%
Net Income	$179,159	$57,948	+2.1%

Key Indicators

✗ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
BRYSON KATONA MD PHD CGAF	PRESIDENT	N/A	Officer	$0	$0	$0
PETE STANICH MD	PAST PRESIDE	N/A	Officer	$0	$0	$0
MICHAEL HALL MD MS CGAF	TREASURER	N/A	Officer	$0	$0	$0
BETH YURKOVICH MS MPH CGC CGAF	PRESIDENT EL	N/A	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$311,413	$132,254	$808,388	$179,159
2023	$185,543	$127,595	$650,739	$57,948
2022	$189,135	$89,617	$565,847	$99,518
2021	$250,508	$167,096	No data	$83,412
2020	$227,438	$216,385	No data	$11,053
2019	$400,900	$181,349	$361,865	$219,551

COLLABORATIVE GROUP OF THE AMERICAS INHERITED GASTROINTESTINAL CANCER